Europe
The subscription price for warrant TO1 in Promore Pharma AB has been determined according to the terms and conditions forthe warrants to 23.30 SEK per share.
The first treatment in this final study prior to the application for marketing authorization for the gp-ASIT+™ product candidate on the German market was undertaken on schedule at the Memmingen medical center in Germany
Researchers rejuvenate immune system - Blood-forming stem cells are key to a strong immune defencene
One side effect of getting older is a weakening immune system.
Immunicum AB has, as previously announced, implemented a share issue with preferential rights for the Company’s existing shareholders.
Biom’up today announced the appointment of George Makhoul as Chief Commercial Officer with responsibility for the United States, effective today.
As January ends, biotech and pharma companies tap new leaders to help drive strategic visions. New hires at Histogen, Indalo, Novartis Oncology, Calico, and more.
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
Shares of GlaxoSmithKline took a slight dip Wednesday afternoon after the U.S. Food and Drug Administration approved Mylan NV’s generic version of Advair Diskus, a staple blockbuster drug in the U.K. pharmaceutical company’s pipeline.
Messenger RNA (mRNA) is a family of RNA molecules that transport genetic information from DNA to the ribosome, where it specifies the amino acid sequence that creates proteins. In theory, by coding your own mRNA, it should be possible to insert it into the cells and turn them into protein factories churning out whatever drug or molecule you program it to.
Janssen Pharmaceutical, a Johnson & Johnson company, inked a worldwide collaboration and license deal with MeiraGTx to develop, manufacture and commercialize a portfolio of drugs for inherited retinal diseases.
PRESS RELEASES